Alzheimer's disease: Cost cuts call for novel drugs development and national strategy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18450%2F15%3A50003603" target="_blank" >RIV/62690094:18450/15:50003603 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Alzheimer's disease: Cost cuts call for novel drugs development and national strategy

Popis výsledku v původním jazyce

Mental health affects the quality of life for a large number of individuals and family members. Currently, globally costs for people with dementia amount to more than 1% of gross domestic product (GDP). In the future, the growth of expenditure is expected with regard to the fact that the population of developed countries is aging and the dementia is closely associated with increasing age. It is evident that governments have to allocate adequate financial, material and human resources to address a healthproblem on this scale. The purpose of this article is to explore the current state of treatment and care of patients suffering from Alzheimer's disease (AD), analyze direct and indirect health care costs resulting from this disease. In addition, the authors of this article draw attention to the implementation of a strategic plan which would handle all the aspects of AD, including the research of drugs development since nowadays there are not still many drugs which would improve AD patie

Název v anglickém jazyce

Alzheimer's disease: Cost cuts call for novel drugs development and national strategy

Popis výsledku anglicky

Mental health affects the quality of life for a large number of individuals and family members. Currently, globally costs for people with dementia amount to more than 1% of gross domestic product (GDP). In the future, the growth of expenditure is expected with regard to the fact that the population of developed countries is aging and the dementia is closely associated with increasing age. It is evident that governments have to allocate adequate financial, material and human resources to address a healthproblem on this scale. The purpose of this article is to explore the current state of treatment and care of patients suffering from Alzheimer's disease (AD), analyze direct and indirect health care costs resulting from this disease. In addition, the authors of this article draw attention to the implementation of a strategic plan which would handle all the aspects of AD, including the research of drugs development since nowadays there are not still many drugs which would improve AD patie

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

AE - Řízení, správa a administrativa

OECD FORD obor

—

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Česká a slovenská farmacie

ISSN

1210-7816

e-ISSN

—

Svazek periodika

64

Číslo periodika v rámci svazku

červen

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

25-30

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—